IPCALAB Q1 FY27 results at a glance
IPCA LABORATORIES LTD Q1 FY27 key results metrics| Quarter | Q1 FY27 |
|---|
| Quarter ended | 30 Jun 2026 |
|---|
| Revenue | ₹2,788 cr |
|---|
| Revenue YoY | +20.8% |
|---|
| Operating profit | ₹559 cr |
|---|
| Operating margin | 20.0% |
|---|
| Net profit | ₹402 cr |
|---|
| Net profit YoY | +72.3% |
|---|
| Net profit QoQ | +34.4% |
|---|
| Net margin | 14.4% |
|---|
| Basic EPS | ₹15.84 |
|---|
| TTM revenue | ₹10,126 cr |
|---|
| TTM net profit | ₹1,310 cr |
|---|
| TTM net margin | 12.9% |
|---|
IPCALAB Q1 FY27 results: what the numbers say
IPCA LABORATORIES LTD (IPCALAB) has reported its Q1 FY27 results for the quarter ended 2026-06-30. The company posted revenue of ₹2,788 cr and a net profit of ₹402 cr, translating into earnings per share of ₹15.84.
Compared with the same quarter a year earlier, revenue grew strongly by +20.8% and net profit grew sharply by +72.3%. Profit rising faster than revenue points to better cost control or operating leverage flowing through the P&L.
Operating profit for the quarter stood at ₹559 cr, an operating margin of 20.0% versus 13.7% a year ago — a gain of 6.3 percentage points.
IPCALAB quarter-wise results table
Revenue
₹2,788 cr
+20.8% YoY
Net profit
₹402 cr
+72.3% YoY
Operating profit
₹559 cr
+76.6% YoY
IPCA LABORATORIES LTD (IPCALAB) quarter-wise results — revenue, operating profit, net profit, margins, EPS and growth| Quarter | Revenue | Operating profit | Net profit | OPM | Net margin | EPS | Profit YoY | Profit QoQ |
|---|
| Q1 FY272026-06-30 | ₹2,788 cr | ₹559 cr | ₹402 cr | 20.0% | 14.4% | ₹15.84 | +72.3% | +34.4% |
| Q4 FY262026-03-31 | ₹2,388 cr | ₹377 cr | ₹299 cr | 15.8% | 12.5% | ₹11.79 | — | -8.3% |
| Q3 FY262025-12-31 | ₹2,393 cr | ₹426 cr | ₹326 cr | 17.8% | 13.6% | ₹12.86 | — | +15.5% |
| Q2 FY262025-09-30 | ₹2,557 cr | ₹442 cr | ₹283 cr | 17.3% | 11.1% | ₹11.14 | — | +21.2% |
| Q1 FY262025-06-30 | ₹2,309 cr | ₹316 cr | ₹233 cr | 13.7% | 10.1% | ₹9.19 | — | — |
| TTM (last 4 quarters) | ₹10,126 cr | ₹1,803 cr | ₹1,310 cr | 17.8% | 12.9% | ₹51.63 | — | — |
Consolidated figures as reported to the exchanges, shown in ₹ crore. OPM = operating profit margin. Updated automatically whenever a new quarter is filed.
IPCALAB quarterly income statement
Line-item results for the last six quarters as filed — sales, expenses, operating profit, interest, tax and profit after tax in ₹ crore.
IPCA LABORATORIES LTD quarterly income statement| Particulars | Q1 FY272026-06-30 | Q4 FY262026-03-31 | Q3 FY262025-12-31 | Q2 FY262025-09-30 | Q1 FY262025-06-30 |
|---|
| Revenue / Sales | ₹2,788 cr | ₹2,388 cr | ₹2,393 cr | ₹2,557 cr | ₹2,309 cr |
|---|
| Total expenses | ₹2,229 cr | ₹2,012 cr | ₹1,967 cr | ₹2,115 cr | ₹1,992 cr |
|---|
| Gross profit | ₹1,991 cr | ₹1,697 cr | ₹1,735 cr | ₹1,775 cr | ₹1,617 cr |
|---|
| Operating profit (EBIT) | ₹559 cr | ₹377 cr | ₹426 cr | ₹442 cr | ₹316 cr |
|---|
| Operating margin | 20.0% | 15.8% | 17.8% | 17.3% | 13.7% |
|---|
| Interest cost | ₹11.88 cr | ₹20.2 cr | ₹17.62 cr | ₹19.61 cr | ₹18.51 cr |
|---|
| Profit before tax | ₹572 cr | ₹404 cr | ₹446 cr | ₹392 cr | ₹331 cr |
|---|
| Tax expense | ₹150 cr | ₹95.05 cr | ₹81.93 cr | ₹108 cr | ₹96.09 cr |
|---|
| Effective tax rate | 26.2% | 23.5% | 18.4% | 27.6% | 29.1% |
|---|
| Net profit (PAT) | ₹402 cr | ₹299 cr | ₹326 cr | ₹283 cr | ₹233 cr |
|---|
| Net profit margin | 14.4% | 12.5% | 13.6% | 11.1% | 10.1% |
|---|
| Basic EPS | ₹15.84 | ₹11.79 | ₹12.86 | ₹11.14 | ₹9.19 |
|---|
| Diluted EPS | ₹15.84 | ₹11.79 | ₹12.86 | ₹11.14 | ₹9.19 |
|---|
IPCALAB results growth — YoY and QoQ
Quarterly growth rates, year on year and quarter on quarter| Growth | Q1 FY27 | Q4 FY26 | Q3 FY26 | Q2 FY26 | Q1 FY26 |
|---|
| Revenue YoY | +20.8% | — | — | — | — |
|---|
| Revenue QoQ | +16.7% | -0.2% | -6.4% | +10.7% | — |
|---|
| Operating profit YoY | +76.6% | — | — | — | — |
|---|
| Operating profit QoQ | +48.3% | -11.5% | -3.6% | +39.6% | — |
|---|
| Net profit YoY | +72.3% | — | — | — | — |
|---|
| Net profit QoQ | +34.4% | -8.3% | +15.5% | +21.2% | — |
|---|
| EPS YoY | +72.4% | — | — | — | — |
|---|
| EPS QoQ | +34.4% | -8.3% | +15.4% | +21.2% | — |
|---|
IPCALAB annual results history
Full-year performance for IPCA LABORATORIES LTD, useful for reading each quarter in context.
IPCA LABORATORIES LTD annual income statement| Particulars | FY262026-03-31 | FY252025-03-31 | FY242024-03-31 | FY232023-03-31 |
|---|
| Revenue / Sales | ₹9,563 cr | ₹8,855 cr | ₹7,622 cr | ₹6,207 cr |
|---|
| Total expenses | ₹7,932 cr | ₹7,499 cr | ₹6,688 cr | ₹5,502 cr |
|---|
| Gross profit | ₹6,582 cr | ₹5,924 cr | ₹4,897 cr | ₹3,799 cr |
|---|
| Operating profit (EBIT) | ₹1,630 cr | ₹1,356 cr | ₹934 cr | ₹705 cr |
|---|
| Operating margin | 17.0% | 15.3% | 12.3% | 11.4% |
|---|
| Interest cost | ₹75.73 cr | ₹84.32 cr | ₹137 cr | ₹45.09 cr |
|---|
| Profit before tax | ₹1,573 cr | ₹1,131 cr | ₹843 cr | ₹745 cr |
|---|
| Tax expense | ₹381 cr | ₹344 cr | ₹313 cr | ₹253 cr |
|---|
| Effective tax rate | 24.2% | 30.4% | 37.2% | 34.0% |
|---|
| Net profit (PAT) | ₹1,141 cr | ₹738 cr | ₹547 cr | ₹471 cr |
|---|
| Net profit margin | 11.9% | 8.3% | 7.2% | 7.6% |
|---|
| Basic EPS | ₹44.98 | ₹29.08 | ₹21.57 | ₹18.58 |
|---|
| Diluted EPS | ₹44.98 | ₹29.08 | ₹21.57 | ₹18.58 |
|---|
Revenue trend and demand read-through
Topline for Q1 FY27 came in at ₹2,788 cr against ₹2,309 cr in Q1 FY26, and ₹2,388 cr in the preceding Q4 FY26 quarter.
On a sequential basis revenue grew +16.7%. Sequential moves are the quickest read on demand momentum because they strip out the base effect of a year-old quarter, though seasonality can distort a single quarter.
Total expenses for the quarter were ₹2,229 cr, or 80.0% of revenue, with operating profit grew +76.6% year on year.
Margins, tax and profitability
Net profit of ₹402 cr works out to a net margin of 14.4% compared with 10.1% in the year-ago quarter. Margin expansion of this kind usually reflects a better product or service mix, softer input costs, or tighter overheads.
Below the operating line, IPCA LABORATORIES LTD reported profit before tax of ₹572 cr, a tax charge of ₹150 cr (effective rate 26.2%), interest cost of ₹11.88 cr. Reading these together with operating profit shows how much of the quarter's earnings were driven by the core business versus financing and tax movements.
Sequentially, net profit moved from ₹299 cr in Q4 FY26 to ₹402 cr in Q1 FY27, a change of +34.4%.
Trailing twelve months and annual context
Across the trailing four quarters IPCA LABORATORIES LTD has generated revenue of ₹10,126 cr and net profit of ₹1,310 cr, a trailing net margin of 12.9%. The trailing view smooths out one-off quarters and is the number most valuation multiples are built on.
On a full-year basis, FY26 revenue was ₹9,563 cr with net profit of ₹1,141 cr and EPS of ₹44.98, versus the prior year where revenue grew +8.0% and profit grew +54.7%.
What to watch in the next IPCALAB quarter
For the coming quarters the numbers worth tracking on this page are revenue momentum, the operating margin trend, the interest burden and whether EPS keeps pace with profit growth. A sustained run of year-on-year profit growth is what usually drives a re-rating rather than any single quarter.
IPCA LABORATORIES LTD has not yet intimated its next results date to the exchange. This page refreshes automatically from filings and the board-meeting calendar, so the tables above will reflect the next quarter as soon as it is reported.
All figures here are as reported to the exchanges and shown in ₹ crore, without adjustment. This is information and analysis, not investment advice.
IPCALAB results coverage
No results report published for IPCALAB yet — our desk covers each quarter within minutes of the filing.
IPCALAB quarterly results FAQs
What were IPCA LABORATORIES LTD (IPCALAB) Q1 FY27 results?
In Q1 FY27 (quarter ended 30 Jun 2026), IPCA LABORATORIES LTD reported revenue of ₹2,788 cr and net profit of ₹402 cr, a change of +72.3% year on year on +20.8% revenue growth. EPS stood at ₹15.84.
What is IPCALAB profit margin in Q1 FY27?
IPCA LABORATORIES LTD posted a net profit margin of 14.4% and an operating margin of 20.0% in Q1 FY27. On a trailing twelve-month basis, revenue is ₹10,126 cr and net profit ₹1,310 cr.
Did IPCALAB results beat the previous quarter?
IPCA LABORATORIES LTD net profit changed +34.4% quarter on quarter, from ₹299 cr in Q4 FY26 to ₹402 cr in Q1 FY27.
When are IPCA LABORATORIES LTD (IPCALAB) quarterly results?
IPCA LABORATORIES LTD has not yet intimated its next results date to the exchange. This page updates automatically from the exchange board-meeting calendar.
Where can I see IPCALAB latest quarterly results?
Results coverage for IPCALAB will appear here as soon as the company reports. Meanwhile you can track live price and technicals on the IPCALAB stock page.
What is IPCA LABORATORIES LTD annual revenue and profit?
For FY26, IPCA LABORATORIES LTD reported full-year revenue of ₹9,563 cr and net profit of ₹1,141 cr, with EPS of ₹44.98.
How many quarterly results has IPCALAB declared recently?
Past results dates for IPCALAB will be listed here from the exchange calendar.
Results dates sourced from the exchange board-meeting calendar; reported figures from company filings, last refreshed 12 Sept 2026. For information only, not investment advice.
